Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $512.94 million. The enterprise value is $273.57 million.

Market Cap	512.94M
Enterprise Value	273.57M

Important Dates

The last earnings date was Tuesday, May 5, 2026, before market open.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

CTNM has 37.39 million shares outstanding. The number of shares has increased by 21.17% in one year.

Current Share Class	32.72M
Shares Outstanding	37.39M
Shares Change (YoY)	+21.17%
Shares Change (QoQ)	+20.98%
Owned by Insiders (%)	0.83%
Owned by Institutions (%)	68.79%
Float	27.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.05
P/TBV Ratio	2.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.00, with a Debt / Equity ratio of 0.03.

Current Ratio	38.00
Quick Ratio	37.00
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.88% and return on invested capital (ROIC) is -786.04%.

Return on Equity (ROE)	-26.88%
Return on Assets (ROA)	-18.18%
Return on Invested Capital (ROIC)	-786.04%
Return on Capital Employed (ROCE)	-26.25%
Weighted Average Cost of Capital (WACC)	9.01%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +257.29% in the last 52 weeks. The beta is 0.89, so CTNM's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+257.29%
50-Day Moving Average	13.27
200-Day Moving Average	11.98
Relative Strength Index (RSI)	51.19
Average Volume (20 Days)	196,991

Short Selling Information

The latest short interest is 1.61 million, so 4.29% of the outstanding shares have been sold short.

Short Interest	1.61M
Short Previous Month	3.10M
Short % of Shares Out	4.29%
Short % of Float	5.82%
Short Ratio (days to cover)	6.41

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-66.85M
Pretax Income	-58.44M
Net Income	-58.44M
EBITDA	-66.53M
EBIT	-66.85M
Earnings Per Share (EPS)	-$1.91

Balance Sheet

The company has $246.33 million in cash and $6.95 million in debt, with a net cash position of $239.37 million or $6.40 per share.

Cash & Cash Equivalents	246.33M
Total Debt	6.95M
Net Cash	239.37M
Net Cash Per Share	$6.40
Equity (Book Value)	250.04M
Book Value Per Share	6.69
Working Capital	246.31M

Cash Flow

Operating Cash Flow	-57.17M
Capital Expenditures	-496,000
Depreciation & Amortization	325,750
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.17%
Shareholder Yield	-21.17%
Earnings Yield	-11.39%
FCF Yield	n/a

Analyst Forecast

The average price target for CTNM is $22.33, which is 42.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.33
Price Target Difference	42.13%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-0.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2